Bracing for an expensive round of late-stage studies and potential drug launches as it ramps up work on a slate of new biosimilars, Amgen reported Tuesday evening that it plans to trim up to 15% of the company’s workforce, shutting down facilities in Colorado and Washington state as it slashes up to 2,900 staffers.

…read more

Source: UPDATED: Amgen axing up to 2,900 staffers, shuttering sites in major restructuring


0 No comments